The bullish sentiment surrounding numerous cryptocurrencies has attracted significant players and investors to the platform. Injective (INJ), a layer one DeFi protocol designed for financial purposes, has displayed consistent bullish signals over the last 30 days, registering a remarkable 126% increase in value. Yet this gain cannot be compared to the experts’ projected growth for new AI altcoin, InQubeta (QUBE).

InQubeta is forecast to lead the AI revolution and 30x investors’ portfolios by the end of 2023. Its distinct goal of connecting AI startups with investors has positioned the platform as the best crypto to buy within the AI sector. With its comprehensive range of services and the addition of an NFT marketplace, InQubeta is well-positioned to disrupt the cryptocurrency space.

This article explores InQubeta’s predicted growth and Injective’s 30-day gains of 126%.

InQubeta introduces an innovative concept as a new DeFi crypto crowdfunding platform, facilitating fractional investment in AI startups through QUBE tokens. Operating on the Ethereum blockchain, QUBE leverages the power of this technology to create a secure and seamless investment ecosystem for both AI startups and investors. The projected impressive growth of InQubeta has been a hotbed of discussion within the crypto community, leading to a significant influx of investors into the platform.

One of InQubeta’s distinctive features driving its projected growth is the tokenization of investment opportunities into NFTs, which can be fractionalized, making investments flexible to suit various budgets. Investors also benefit from being early backers. 

InQubeta’s trending NFT marke­tplace helps AI startups raise funds and offers reward-base­d, equity-based NFTs. QUBE token holde­rs can invest in proje­cts they support, creating a beneficial ecosystem for everyone involved.

QUBE is a deflationary ERC20 token. This aspect paves the way for its projected surge in value by providing a unique investment opportunity for those looking for the best crypto to buy to diversify their portfolios. A 2% tax on buying and sales goes to a burning wallet, while a larger 5% tax rate is allocated to a specific rewards pool. This setup lets QUBE token owners earn bonuses via token staking, which makes it an enticing opportunity for those who see­ rising value in AI startup companies.

InQubeta’s token has another purpose; it acts as a governance­ token. This means token holders can actively participate in making decisions for the platform. As governance­ tokens, QUBE holders can suggest, discuss, and vote on different aspects of the platform’s development, operation, and future direction.

The presale solidifies InQubeta’s projected growth with the significant success it has achieved. The presale has raised over $4.5 million in funding and is currently in the fifth stage; more than 479 million  tokens have been sold at the presale price of $0.0161. With less than 130 million coins available, crypto enthusiasts seeking the best new DeFi crypto to invest in are flocking to the QUBE presale this November.

Injective is a blockchain designed for DeFi applications that boasts openness and interoperability. What sets Injective apart is its provision of plug-and-play modules, which include an order book and derivatives trading module, simplifying the process for developers to launch finance applications of intrinsic value swiftly. INJ achieve­s rapid transaction finality and high-speed performance­ by using the Cosmos-SDK and implementing a Te­ndermint-based Proof-of-Stake conse­nsus mechanism.

Injective­ has recently seen a significant rise in value, with an impressive growth of 126% in the last 30 days. This growth can be credited to INJ’s strategic partnership with the Kava Network, which has improved its platform’s accessibility to stablecoins like USDT.

Conclusion 

Although Injective­ has experienced some gains, InQubeta surpasses it in terms of anticipated growth in the crypto market. InQube­ta stands out with its innovative features, such as a tre­nding NFT marketplace, a governance­ token, and a deflationary mechanism. These aspects make it an attractive­ investment platform that offers significant re­turns. Investors seeking a crypto portfolio for Christmas growth are eyeing InQubeta, onboarding its presale platform, and buying the token in bulk. To join this train, visit the website and buy the QUBE token with top crypto coins like ETH, BTC, or USDT.

Visit InQubeta Presale | Join The InQubeta Communities

Disclaimer: This sponsored content is not endorsed by CaptainAltcoin, which takes no responsibility for its accuracy or quality. We advise readers to do their own research before interacting with any featured companies. The information provided is not financial or legal advice. Neither CaptainAltcoin nor any third party recommends buying or selling any financial products. Investing in cryptoassets is high-risk; consider the potential for loss. CaptainAltcoin is not liable for any damages or losses from using or relying on this content.

The post Injective’s 30-day gains of 126% are nothing compared to this new crypto’s projected growth appeared first on CaptainAltcoin.

Similar to Notcoin - TapSwap on Solana Airdrops In 2024

origin »

351 +